Literature DB >> 26546431

A c-Myc/miR-17-5p feedback loop regulates metastasis and invasion of hepatocellular carcinoma.

Dongli Liu1, Lili Dong1, Yang Liu1, Duo Wen2, Dongmei Gao1, Huichuan Sun1, Jia Fan1,3, Weizhong Wu4.   

Abstract

The molecular mechanisms that control metastasis of hepatocellular cancer (HCC) are still poorly understood. It has been determined that microRNA (miRNA) expression has tissue and cell specific, and decreased expression of specific miRNA could induce tumor genesis or metastasis. In this study, we identified that miR-17-5p was expressed lower in high metastatic capability HCC cell lines HCCLM3 and MHCC97H than low metastatic HCC cell line HepG2 by real-time (RT)-PCR. Restoration of miR-17-5p could significantly repress the invasiveness and metastasis of MHCC97H cell line. Furthermore, we validated c-Myc as a downstream and functional target of miR-17-5p using luciferase reporter assay. Immunohistochemical assay revealed that the expression of c-Myc protein levels was significantly increased in cancerous tissues compared with para-tumor tissues. After clinical data analysis, we observed that the higher level of c-Myc was significantly associated with a reduced overall survival (p = 0.0209). Consistent with previous research, we also demonstrated that c-Myc could upregulate the expression of miR-17-5p. Taken together, our data indicated that there is a regulatory feedback loop between miR-17-5p and c-Myc, in which miR-17-5p could suppress some of the distinguishing features, invasion, and metastasis, of oncogenic c-Myc in HCC cells, and meanwhile, miR-17-5p is upregulated by c-Myc role as a transcription factor, although further studies are still needed.

Entities:  

Keywords:  Hepatocellular carcinoma (HCC); Invasion; Metastasis; Regulatory feedback loop; c-Myc; miR-17-5p

Mesh:

Substances:

Year:  2015        PMID: 26546431     DOI: 10.1007/s13277-015-4355-5

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  38 in total

1.  Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer.

Authors:  Maricarmen D Planas-Silva; Richard D Bruggeman; Ronald T Grenko; J S Smith
Journal:  Exp Mol Pathol       Date:  2006-10-13       Impact factor: 3.362

2.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

Review 3.  MYC on the path to cancer.

Authors:  Chi V Dang
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

4.  A microRNA polycistron as a potential human oncogene.

Authors:  Lin He; J Michael Thomson; Michael T Hemann; Eva Hernando-Monge; David Mu; Summer Goodson; Scott Powers; Carlos Cordon-Cardo; Scott W Lowe; Gregory J Hannon; Scott M Hammond
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.

Authors:  Y Li; Y Tang; L Ye; B Liu; K Liu; J Chen; Q Xue
Journal:  J Cancer Res Clin Oncol       Date:  2002-12-04       Impact factor: 4.553

6.  High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma.

Authors:  Xiao-Dong Zhu; Ju-Bo Zhang; Peng-Yuan Zhuang; Hong-Guang Zhu; Wei Zhang; Yu-Quan Xiong; Wei-Zhong Wu; Lu Wang; Zhao-You Tang; Hui-Chuan Sun
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

Review 7.  Metabolic defects provide a spark for the epigenetic switch in cancer.

Authors:  Michael J Hitchler; Frederick E Domann
Journal:  Free Radic Biol Med       Date:  2009-04-10       Impact factor: 7.376

8.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells.

Authors:  Zirong Li; Sara Van Calcar; Chunxu Qu; Webster K Cavenee; Michael Q Zhang; Bing Ren
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

9.  A mammalian microRNA expression atlas based on small RNA library sequencing.

Authors:  Pablo Landgraf; Mirabela Rusu; Robert Sheridan; Alain Sewer; Nicola Iovino; Alexei Aravin; Sébastien Pfeffer; Amanda Rice; Alice O Kamphorst; Markus Landthaler; Carolina Lin; Nicholas D Socci; Leandro Hermida; Valerio Fulci; Sabina Chiaretti; Robin Foà; Julia Schliwka; Uta Fuchs; Astrid Novosel; Roman-Ulrich Müller; Bernhard Schermer; Ute Bissels; Jason Inman; Quang Phan; Minchen Chien; David B Weir; Ruchi Choksi; Gabriella De Vita; Daniela Frezzetti; Hans-Ingo Trompeter; Veit Hornung; Grace Teng; Gunther Hartmann; Miklos Palkovits; Roberto Di Lauro; Peter Wernet; Giuseppe Macino; Charles E Rogler; James W Nagle; Jingyue Ju; F Nina Papavasiliou; Thomas Benzing; Peter Lichter; Wayne Tam; Michael J Brownstein; Andreas Bosio; Arndt Borkhardt; James J Russo; Chris Sander; Mihaela Zavolan; Thomas Tuschl
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

10.  Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses.

Authors:  J Blancato; B Singh; A Liu; D J Liao; R B Dickson
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

View more
  11 in total

1.  MicroRNA-204 suppressed proliferation and motility capacity of human hepatocellular carcinoma via directly targeting zinc finger E-box binding homeobox 2.

Authors:  Bin Hu; Ming Sun; Jiajun Liu; Guolin Hong; Qin Lin
Journal:  Oncol Lett       Date:  2017-03-24       Impact factor: 2.967

2.  A miRNAs panel promotes the proliferation and invasion of colorectal cancer cells by targeting GABBR1.

Authors:  Yang Longqiu; Luo Pengcheng; Fei Xuejie; Zhang Peng
Journal:  Cancer Med       Date:  2016-05-27       Impact factor: 4.452

Review 3.  Oncogenic MicroRNAs: Key Players in Malignant Transformation.

Authors:  Tania Frixa; Sara Donzelli; Giovanni Blandino
Journal:  Cancers (Basel)       Date:  2015-12-18       Impact factor: 6.639

4.  ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation.

Authors:  Yi Yuan; Durkeshwari Anbalagan; Lay Hoon Lee; Ramar Perumal Samy; Muthu K Shanmugam; Alan Prem Kumar; Gautam Sethi; Peter E Lobie; Lina H K Lim
Journal:  Oncotarget       Date:  2016-05-10

5.  miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.

Authors:  Jie Li; Yuanhui Lai; Jieyi Ma; Yue Liu; Jiong Bi; Longjuan Zhang; Lianzhou Chen; Chen Yao; Weiming Lv; Guangqi Chang; Shenming Wang; Mao Ouyang; Wenjian Wang
Journal:  BMC Cancer       Date:  2017-11-10       Impact factor: 4.430

6.  Prognostic value of miR-17-5 p in gastrointestinal cancers: a systematic review and meta-analysis.

Authors:  Zeyu Wang; Jing Zhang; Zhiguang Zhang; Yong Jiang; Man Li; Qian Li; Lu Bai; Dongying Yao; Miao Wang; Xiaoping Wang
Journal:  Onco Targets Ther       Date:  2018-09-19       Impact factor: 4.147

7.  Interplay of miRNAs and Canonical Wnt Signaling Pathway in Hepatocellular Carcinoma.

Authors:  Xiaobo Nie; Yiran Liu; Wei-Dong Chen; Yan-Dong Wang
Journal:  Front Pharmacol       Date:  2018-06-21       Impact factor: 5.810

8.  Prognostic value of miR-17-5p in cancers: a meta-analysis.

Authors:  Weihao Kong; Yusheng Cheng; Hao Liang; Qiangxing Chen; Cuicui Xiao; Kun Li; Zenan Huang; Jian Zhang
Journal:  Onco Targets Ther       Date:  2018-06-19       Impact factor: 4.147

Review 9.  Intricate crosstalk between MYC and non-coding RNAs regulates hallmarks of cancer.

Authors:  Lotteke J Y M Swier; Agnieszka Dzikiewicz-Krawczyk; Melanie Winkle; Anke van den Berg; Joost Kluiver
Journal:  Mol Oncol       Date:  2018-12-05       Impact factor: 6.603

10.  LINC01939 inhibits the metastasis of gastric cancer by acting as a molecular sponge of miR-17-5p to regulate EGR2 expression.

Authors:  Mi Chen; Li Fan; Si-Min Zhang; Yong Li; Peng Chen; Xin Peng; Dong-Bo Liu; Charlie Ma; Wen-Jie Zhang; Zhen-Wei Zou; Pin-Dong Li
Journal:  Cell Death Dis       Date:  2019-01-25       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.